These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 16426731

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Role of transperineal six-core prostate biopsy in patients with prostate-specific antigen level greater than 10 ng/mL and abnormal digital rectal examination findings.
    Luciani LG, De Giorgi G, Valotto C, Zanin M, Bierti S, Zattoni F.
    Urology; 2006 Mar; 67(3):555-8. PubMed ID: 16527579
    [Abstract] [Full Text] [Related]

  • 23. Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy.
    Suekane S, Noguchi M, Nakashima O, Yamada S, Kojiro M, Matsuoka K.
    Int J Urol; 2007 Aug; 14(8):713-8. PubMed ID: 17681061
    [Abstract] [Full Text] [Related]

  • 24. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
    Schoenfield L, Jones JS, Zippe CD, Reuther AM, Klein E, Zhou M, Magi-Galluzzi C.
    BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
    [Abstract] [Full Text] [Related]

  • 25. Importance of peripheral biopsies in maximising the detection of early prostate cancer in repeat 12-core biopsy protocols.
    Philip J, Hanchanale V, Foster CS, Javlé P.
    BJU Int; 2006 Sep; 98(3):559-62. PubMed ID: 16925754
    [Abstract] [Full Text] [Related]

  • 26. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO, Hricak H, Wheeler TM, Coleman J, Penson DF, Carroll PR, Rubin MA, Scardino PT.
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [Abstract] [Full Text] [Related]

  • 27. Extensive biopsies and transurethral prostate resection in men with previous negative biopsies and high or increasing prostate specific antigen.
    Ploussard G, Dubosq F, Boublil V, Allory Y, de la Taille A, Vordos D, Hoznek A, Abbou CC, Salomon L.
    J Urol; 2009 Oct; 182(4):1342-9. PubMed ID: 19683310
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy.
    Campos-Fernandes JL, Bastien L, Nicolaiew N, Robert G, Terry S, Vacherot F, Salomon L, Allory Y, Vordos D, Hoznek A, Yiou R, Patard JJ, Abbou CC, de la Taille A.
    Eur Urol; 2009 Mar; 55(3):600-6. PubMed ID: 18597923
    [Abstract] [Full Text] [Related]

  • 30. Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods.
    Yossepowitch O, Eggener SE, Bianco FJ, Carver BS, Serio A, Scardino PT, Eastham JA.
    J Urol; 2007 Aug; 178(2):493-9; discussion 499. PubMed ID: 17561152
    [Abstract] [Full Text] [Related]

  • 31. Individualized prostate biopsy strategy for Chinese patients with different prostate-specific antigen levels.
    Dai B, Ye DW, Kong YY, Shen YJ, Wang BH.
    Asian J Androl; 2008 Mar; 10(2):325-31. PubMed ID: 18097514
    [Abstract] [Full Text] [Related]

  • 32. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer.
    Sengupta S, Blute ML, Bagniewski SM, Inman B, Leibovich BC, Slezak JM, Myers RP, Zincke H.
    BJU Int; 2008 Jan; 101(2):170-4. PubMed ID: 18173824
    [Abstract] [Full Text] [Related]

  • 33. Prostate cancer volume at biopsy predicts clinically significant upgrading.
    Dong F, Jones JS, Stephenson AJ, Magi-Galluzzi C, Reuther AM, Klein EA.
    J Urol; 2008 Mar; 179(3):896-900; discussion 900. PubMed ID: 18207180
    [Abstract] [Full Text] [Related]

  • 34. Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection.
    Chiang IN, Chang SJ, Pu YS, Huang KH, Yu HJ, Huang CY.
    Urol Int; 2009 Mar; 82(3):270-5. PubMed ID: 19440012
    [Abstract] [Full Text] [Related]

  • 35. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens.
    Divrik RT, Eroglu A, Sahin A, Zorlu F, Ozen H.
    Urol Oncol; 2007 Mar; 25(5):376-82. PubMed ID: 17826653
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Evaluation of the prostate peripheral zone/capsule in patients undergoing radical cystoprostatectomy: defining risk with prostate capsule sparing cystectomy.
    Weizer AZ, Shah RB, Lee CT, Gilbert SM, Daignault S, Montie JE, Wood DP.
    Urol Oncol; 2007 Mar; 25(6):460-4. PubMed ID: 18047952
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation.
    Pepe P, Aragona F.
    Urology; 2007 Dec; 70(6):1131-5. PubMed ID: 18158033
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.